Aethlon Medical Inc. is a pioneering company in the development of innovative medical technologies aimed at addressing unmet needs in global health. Primarily, the company focuses on developing therapies for life-threatening conditions, including infectious diseases and cancer. A key product in their portfolio is the Hemopurifier, a therapeutic device designed to selectively capture and eliminate harmful viruses, cancer-specific particles, and exosomes from the circulatory system. Aethlon Medical’s groundbreaking work particularly impacts sectors such as medical technology and biotechnology, driving advances in treatments that serve a critical role during pandemics or targeted cancer therapies. The company operates within a crucial segment of the healthcare industry, emphasizing novel treatment methods that hold the potential to transform standard care practices. Based in the United States, Aethlon Medical Inc. contributes significantly to the research and development landscape, ensuring that its cutting-edge solutions meet the rigorous demands of combating complex medical challenges worldwide.